-
Enhancing activity of FcαRI-bispecific antibodies using glycoengineering
Sewnath, C. L. A. N., Damelang, T., Bentlage, A. E. H., Kroode, L. T., Tuk, C. W., Visser, R., Wuhrer, M., van Coillie, J., Rispens, T., van Egmond, M. & Vidarsson, G., 1 Jun 2025, In: Journal of Immunology. 214, 6, p. 1261-1271 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Nk cell-dependent antibody-mediated immunotherapy is improved in vitro and in vivo when combined with agonists for toll-like receptor 2 in head and neck cancer models
Gruijs, M., Ganzevles, S. H., Stigter-Van Walsum, M., van der Mast, R., van Ostaijen-Ten Dam, M. M., Tuk, C. W., Schilham, M. W., Leemans, C. R., Brakenhoff, R. H., van Egmond, M., van de Ven, R. & Bakema, J. E., 1 Oct 2021, In: International journal of molecular sciences. 22, 20, 11057.Research output: Contribution to journal › Article* › Academic › peer-review
-
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
Heemskerk, N., Gruijs, M., Robin Temming, A., Heineke, M. H., Gout, D. Y., Hellingman, T., Tuk, C. W., Winter, P. J., Lissenberg-Thunnissen, S., Bentlage, A. E. H., de Donatis, M., Bögels, M., Rösner, T., Valerius, T., Bakema, J. E., Vidarsson, G. & van Egmond, M., 15 Mar 2021, In: Journal of Clinical Investigation. 131, 6, e134680.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
